Ellen Neven Selected Research

Adenine

1/2022	Sclerostin Protects Against Vascular Calcification Development in Mice.
10/2020	Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.
1/2018	Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
11/2016	Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?
12/2015	Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
6/2013	Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
9/2010	Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats.
6/2009	Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats.
9/2006	High-resolution X-ray microtomography is a sensitive method to detect vascular calcification in living rats with chronic renal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ellen Neven Research Topics

Disease

16	Vascular Calcification 01/2022 - 09/2006
10	Chronic Kidney Failure (Chronic Renal Failure) 07/2021 - 09/2006
5	Chronic Renal Insufficiency 01/2022 - 11/2016
4	Hyperphosphatemia 07/2021 - 06/2013
3	Inflammation (Inflammations) 01/2022 - 01/2018
3	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 10/2020 - 02/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2018
2	Hypocalcemia 07/2021 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2017 - 02/2016
2	Uremia 06/2013 - 09/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Renal Insufficiency (Renal Failure) 10/2020
1	Acute-Phase Reaction 01/2019
1	Glucose Intolerance 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 12/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardio-Renal Syndrome 06/2017
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 06/2017
1	Hypercalcemia (Milk Alkali Syndrome) 06/2013
1	Hyperparathyroidism 11/2012
1	Iron Deficiencies 04/2011
1	Osteoporosis 01/2011

Drug/Important Bio-Agent (IBA)

9	Adenine FDA LinkGeneric 01/2022 - 09/2006
7	Phosphates (Orthophosphate)IBA 10/2020 - 06/2009
6	CalciumIBA 01/2020 - 06/2009
4	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2018
4	MineralsIBA 10/2020 - 02/2016
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	EnzymesIBA 07/2021 - 01/2020
2	Alkaline PhosphataseIBA 07/2021 - 01/2020
2	Biological ProductsIBA 01/2020 - 09/2010
2	diphosphoric acid (pyrophosphoric acid)IBA 01/2020 - 11/2016
2	Sevelamer (RenaGel)FDA Link 11/2016 - 06/2013
2	calcium acetate (Phoslo)FDA LinkGeneric 01/2014 - 06/2013
2	magnesium carbonate (magnesite)FDA Link 01/2014 - 06/2013
2	MagnesiumIBA 01/2014 - 06/2013
1	CanagliflozinIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	SodiumIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	CreatinineIBA 07/2021
1	sucroferric oxyhydroxideIBA 10/2020
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2020
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2020
1	Inositol PhosphatesIBA 01/2020
1	IonsIBA 01/2020
1	SBI-425IBA 01/2020
1	CollagenIBA 11/2019
1	Poly Adenosine Diphosphate RiboseIBA 11/2019
1	IndicanIBA 01/2019
1	Sulfates (Sulfates, Inorganic)IBA 01/2019
1	Liver X ReceptorsIBA 01/2019
1	Durapatite (Hydroxylapatite)IBA 11/2016
1	Vitamin K FDA Link 12/2015
1	Cinacalcet (Sensipar)FDA Link 11/2012
1	Vitamin D FDA LinkGeneric 11/2012
1	Calcitriol (Calcijex)FDA LinkGeneric 11/2012
1	Phosphorus (Red Phosphorus)IBA 11/2012
1	IronIBA 04/2011
1	salicylhydroxamic acid (SHAM)IBA 01/2011
1	lanthanum carbonate (Fosrenol)FDA Link 06/2009
1	calcium phosphateIBA 06/2009
1	antineoplaston A10 (A 10)IBA 09/2006

Therapy/Procedure

2	Therapeutics 01/2018 - 06/2017
2	Protein-Restricted Diet (Diet, Protein Restricted) 11/2016 - 09/2010
1	Transplantation 12/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2018
1	Ovariectomy (Oophorectomy) 01/2011